Prostate cancer develops in the prostate gland, a walnut-sized organ that produces fluid for semen. According to the American Cancer Society, prostate cancer is the most commonly diagnosed cancer in American men, with roughly 1 in 8 men receiving a diagnosis during their lifetime. However, the word "cancer" doesn't mean the same thing for every person—prostate cancer varies dramatically in how fast it grows and how much danger it poses.
Learn About Paying Your FGUA Bill Online →
When doctors discover prostate cancer, one of the first steps involves determining how aggressive it is. This matters enormously because some prostate cancers grow so slowly that they may never cause serious harm, while others advance more rapidly and require urgent treatment. Doctors use several tools to understand your specific cancer: a Gleason score (which rates how abnormal the cancer cells look under a microscope on a scale of 2-10), a PSA level (a protein in the blood), and the stage of the cancer (whether it's confined to the prostate or has spread).
Different treatment paths exist because different cancers demand different responses. A 72-year-old man with a slow-growing cancer contained within the prostate might pursue an entirely different approach than a 55-year-old with aggressive cancer that shows signs of spreading. This guide explores the major treatment categories so you understand what doctors might recommend and why.
Practical takeaway: Before exploring treatment options, you'll want to understand your cancer's characteristics—the Gleason score, PSA level, and stage. These numbers shape which treatments your doctor will likely suggest.
Active surveillance sounds counterintuitive—you have cancer but you're not treating it yet. However, this approach makes sense for many men because some prostate cancers grow so slowly that they never cause problems. Research shows that a substantial portion of men diagnosed with low-risk prostate cancer will never need aggressive treatment during their lifetime.
Free Guide to Pay by Plate Illinois Billing →
In active surveillance, your doctor monitors your cancer closely rather than jumping immediately to surgery or radiation. You'll typically have PSA blood tests every 3-6 months and periodic digital rectal exams (where the doctor feels the prostate through the rectal wall). Many doctors also recommend repeat biopsies every 1-3 years to confirm the cancer hasn't become more aggressive. Some medical centers use MRI imaging to track the cancer's characteristics over time.
This approach preserves your quality of life by avoiding the side effects of surgery or radiation—potential urinary problems, erectile dysfunction, and bowel issues—if they're not necessary. Studies following men on active surveillance for 10-15 years show that many never progress to needing treatment. However, active surveillance demands commitment: you must attend regular appointments and be prepared to begin treatment if your cancer shows signs of becoming more aggressive.
Active surveillance works best for men with low-risk cancer (Gleason score of 6 or less, PSA under 10, and cancer confined to a small area of the prostate). It's less suitable for younger men or those with higher-risk cancers that may become dangerous if left untreated.
Practical takeaway: If your cancer is low-risk and slow-growing, active surveillance lets you avoid treatment side effects while keeping close watch. This requires regular doctor visits and the willingness to start treatment if the cancer changes.
Surgery to remove the entire prostate gland—called a radical prostatectomy—remains one of the most common treatments for prostate cancer, especially for men with cancer confined to the prostate and a life expectancy of at least 10-15 years. The goal is to remove all cancer cells while preserving surrounding tissues, particularly the nerves that control urination and erectile function.
Free Guide to Mold Removal Methods for Walls →
Surgeons perform this procedure through several different approaches. Traditional open surgery involves a single incision in the lower abdomen or between the scrotum and anus. Robotic-assisted surgery, which became widely available in the 2000s, uses small instruments guided by the surgeon through several tiny incisions. Laparoscopic surgery (minimally invasive without robotic assistance) is less common now but still performed at some centers. Studies comparing these approaches show similar cancer outcomes, though robotic-assisted surgery typically involves smaller incisions, less bleeding, shorter hospital stays, and potentially faster recovery than traditional open surgery.
The major tradeoff with surgery is potential side effects. Urinary incontinence (inability to control urine) occurs in roughly 20-30% of men after surgery, though the severity varies—some experience occasional leakage with physical activity, while others have more significant problems. Erectile dysfunction occurs in many men, particularly those over 65, though nerve-sparing techniques (where surgeons try to preserve the nerves controlling erections) reduce this risk. These side effects often improve over months or years, but some men experience them permanently.
Surgery works well for cancer that hasn't spread beyond the prostate and for men healthy enough to tolerate the operation. It's less suitable for men with serious heart, lung, or other medical conditions that make surgery risky, or for those with advanced cancer that has spread to distant parts of the body.
Practical takeaway: Surgery offers the chance to remove all cancer at once but carries risks of urinary and sexual side effects. Recovery typically takes several weeks, with improved function over months.
Radiation therapy uses high-energy beams to damage cancer cell DNA, killing the cells or stopping them from dividing. For prostate cancer, this offers an alternative to surgery for men who want to avoid an operation or who may not be healthy enough for surgery. Radiation works for localized cancer (contained in the prostate) and for some cases where cancer has spread slightly beyond the prostate.
How to Delete Your Fitbit Account Guide →
Two main types of radiation treatment serve prostate cancer patients. External beam radiation therapy (EBRT) involves daily visits to a radiation center where a machine directs beams at the cancer from outside the body. Treatments typically occur five days a week for 7-9 weeks. Modern EBRT uses intensity-modulated radiation therapy (IMRT) or proton therapy, which shape the radiation beams to match the prostate's shape, reducing damage to surrounding healthy tissue. Brachytherapy, the second type, involves placing radioactive seeds or implants directly into the prostate through the skin. Seeds are either permanent (they gradually lose radioactivity over months) or temporary (removed after treatment). Brachytherapy typically requires one to several outpatient procedures.
Radiation side effects differ from surgery's. During treatment, men often experience fatigue, urinary frequency or urgency, and occasional rectal irritation. These usually fade after treatment ends. Long-term effects can include some urinary problems and erectile dysfunction, though the rate varies by technique and dose. Interestingly, brachytherapy often causes fewer long-term urinary problems than EBRT, though rectal effects may linger longer for some men.
Radiation works well for all risk levels of prostate cancer. It's particularly valuable for older men, those with serious health conditions making surgery risky, and those who prefer to avoid surgery. It's also used alongside hormone therapy for higher-risk cancers, since radiation alone may not control more aggressive disease.
Practical takeaway: Radiation offers a non-surgical way to treat prostate cancer through repeated outpatient sessions (EBRT) or implanted radioactive seeds (brachytherapy). Side effects differ from surgery but are often manageable.
Prostate cancer cells need testosterone (and similar male hormones called androgens) to grow. Hormone therapy starves cancer cells by either lowering testosterone levels in the body or blocking hormones from reaching cancer cells. This treatment doesn't cure prostate cancer but can slow its growth and spread for months or years, making it valuable for advanced disease or as a companion to radiation or surgery.
Learn How to Grow Sweet Corn at Home →
Doctors use several types of hormone therapy medications. Androgen deprivation therapy (ADT) lowers testosterone production through injections given monthly, every three months, or every six months. Common medications include leuprolide, goserelin, and triptorelin. Anti-androgens block testosterone's effects on cancer cells without lowering testosterone levels; examples include bicalutamide
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.